| Literature DB >> 33610576 |
Yu Liu1, Xinyi Shen2, Mingchang Pang1, Zhen Sun2, Yongjiang Qian2, Wenxin Xue1, Zhongqun Wang2, Lihua Li3.
Abstract
Atherosclerosis (AS) is the most common cause of death in cardiovascular diseases and poses severe challenges to human life and safety. Epigenetics plays a vital role in every single link of AS. Whereas, how epigenetics regulates its development and regression is still unknown. Sirt3, a recognized histone deacetylase, having been reported to be involved in other acylation processes in recent years, is broadening its role in epigenetic modifications. Sirt3 is an important factor in the normal physiology of blood vessels through deacetylation of mitochondrial proteins and participates in various metabolic activities. Besides, medical research targeting Sirt3 is in full swing as well. This review combining histone deacetylase Sirt3 with AS, aims to clarify the latest progress in the significant role of Sirt3 in the development and regression of AS and to provide a novel prospect for a new regulatory factor and potential intervention target for AS.Entities:
Keywords: Atherosclerosis; Epigenetics; Histone deacetylase; Sirt3
Mesh:
Substances:
Year: 2021 PMID: 33610576 DOI: 10.1016/j.lfs.2021.119178
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037